tradingkey.logo
tradingkey.logo
Search

agilon health inc

AGL
Add to Watchlist
99.190USD
+0.760+0.77%
Close 07-28 16:00ETQuotes delayed by 15 min
1.65BMarket Cap
LossP/E TTM

Earnings Forecast

Currency: USD Updated: 2026-07-28
Previous score
6.00
Change
0.24
The current earnings forecast score of agilon health inc is 6.24, ranking 60 out of 75 in the Healthcare Providers & Services industry. The average price target is 1.00, with a high of 2.00 and a low of 0.25.

Analyst Rating

Based on 17 analysts
Hold
Current Rating
67.712
Target Price
-30.91%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

58
Total
9
Median
10
Average
Company name
Ratings
Analysts
agilon health inc
AGL
17
CVS Health Corp
CVS
29
Teladoc Health Inc
TDOC
27
HCA Healthcare Inc
HCA
26
Natera Inc
NTRA
24
Tenet Healthcare Corp
THC
23
1
2
3
...
12

Support & Resistance

Relevant data have not been disclosed by the company yet.

Financial Forecasting

EPS
Revenue
Net Profit
EBIT
Forecast
Actual

FAQs

What is agilon health inc's expected revenue for the next quarter?

agilon health inc's expected revenue is 1.45B.

What is agilon health inc's price target?

Analysts forecast that agilon health inc's price target is USD 1.00, with the highest forecast at USD 2.00 and the lowest forecast at USD 0.25.

How have agilon health incAGL's recent earnings per share performed?

The market expectation was USD 2.95, while agilon health incAGL's earnings per share (EPS) for the previous quarter was USD -11.39. EPS for the next quarter is expected at USD -0.12.

What is the analyst rating for agilon health inc?

Based on the ratings of agilon health inc's stock from 17 analysts, most analysts support a signal_hold trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as signal_hold. Please note that this is not trading advice. You still need to conduct your own analysis.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.